Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Xintec Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Xintec şirketinin toplam hissedar öz sermayesi NT$8.1B ve toplam borcu NT$388.5M olup, bu da borç-öz sermaye oranını 4.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NT$11.1B ve NT$3.1B dir. Xintec 'in FAVÖK'ü NT$1.9B faiz karşılama oranı -37.2 dur. Şirketin NT$4.4B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

4.8%

Borç/özkaynak oranı

NT$388.46m

Borç

Faiz karşılama oranı	-37.2x
Nakit	NT$4.42b
Eşitlik	NT$8.06b
Toplam yükümlülükler	NT$3.07b
Toplam varlıklar	NT$11.13b

Son finansal sağlık güncellemeleri

Is Xintec (GTSM:3374) Using Too Much Debt?

Dec 30

Recent updates

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Apr 16

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Mar 29

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 11

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

Feb 18

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Dec 15

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Nov 30

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3374 'nin kısa vadeli varlıkları ( NT$6.1B ) kısa vadeli yükümlülüklerini ( NT$2.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: 3374 şirketinin kısa vadeli varlıkları ( NT$6.1B ) uzun vadeli yükümlülüklerini ( NT$954.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3374 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 3374 'nin borç/öz sermaye oranı son 5 yılda 75.4% seviyesinden 4.8% seviyesine düştü.

Borç Kapsamı: 3374 'nin borcu işletme nakit akışı ( 536.6% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 3374 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Xintec Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Xintec (GTSM:3374) Using Too Much Debt?

Recent updates

Investor sentiment deteriorates as stock falls 16%

Price target increased by 45% to NT$186

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Xintec Inc. to Report Q2, 2024 Results on Aug 08, 2024

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Upcoming dividend of NT$2.00 per share

Investor sentiment improves as stock rises 23%

Dividend of NT$2.00 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Xintec Inc. to Report Q1, 2024 Results on May 09, 2024

Xintec Inc., Annual General Meeting, May 30, 2024

Third quarter 2023 earnings released: EPS: NT$1.89 (vs NT$2.22 in 3Q 2022)

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NT$3.00 per share at 2.3% yield

Investor sentiment improves as stock rises 22%

Xintec Inc. Appoints Mike Liang as Independent Director

Price target decreased by 7.4% to NT$119

Full year 2022 earnings: EPS exceeds analyst expectations

Xintec Inc. to Report Q4, 2022 Results on Feb 09, 2023

Price target decreased to NT$118

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase by 26%

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$3.00 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to NT$117

Insufficient new directors

Consensus EPS estimates fall by 23%

Full year 2021 earnings: EPS and revenues miss analyst expectations

Xintec Inc., Annual General Meeting, May 26, 2022

Xintec Inc. to Report Q4, 2021 Results on Feb 10, 2022

Insufficient new directors

Insufficient new directors

Investor sentiment improved over the past week

Upcoming dividend of NT$2.50 per share

Investor sentiment deteriorated over the past week

Price target decreased to NT$166

Consensus EPS estimates fall to NT$7.08

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Consensus EPS estimates fall to NT$8.54

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue misses expectations

Xintec Inc., Annual General Meeting, May 27, 2021

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

This Xintec Inc. (GTSM:3374) Analyst Is Way More Bearish Than They Used To Be

What Is Xintec Inc.'s (GTSM:3374) Share Price Doing?

Here's Why I Think Xintec (GTSM:3374) Is An Interesting Stock

Is Xintec (GTSM:3374) Using Too Much Debt?

Investor sentiment deteriorated over the past week

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Market bids up stock over the past week

New 90-day high: NT$199

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Third quarter 2020 earnings released: EPS NT$2.21

Third quarter 2020 earnings released: EPS NT$2.20

Market bids up stock over the past week

New 90-day high: NT$135

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin